CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
0.3884
4.02%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.0072
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026151 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026151%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003929 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003929%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Genprex Inc ESG Risk Ratings

High Medium Low Negligible

‘D’ score indicates poor relative ESG performance and insufficient degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 0.3734
Open* 0.3855
1-Year Change* -72.66%
Day's Range* 0.3754 - 0.3934
52 wk Range 0.43-1.94
Average Volume (10 days) 270.61K
Average Volume (3 months) 15.09M
Market Cap 30.06M
P/E Ratio -100.00K
Shares Outstanding 59.41M
Revenue N/A
EPS -0.61
Dividend (Yield %) N/A
Beta -0.15
Next Earnings Date Nov 14, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Sep 29, 2023 0.3884 0.0029 0.75% 0.3855 0.3945 0.3754
Sep 28, 2023 0.3734 -0.0100 -2.61% 0.3834 0.3869 0.3664
Sep 27, 2023 0.3684 -0.0160 -4.16% 0.3844 0.4002 0.3666
Sep 26, 2023 0.3908 0.0134 3.55% 0.3774 0.3984 0.3774
Sep 25, 2023 0.3774 0.0055 1.48% 0.3719 0.3935 0.3676
Sep 22, 2023 0.3747 -0.0296 -7.32% 0.4043 0.4214 0.3747
Sep 21, 2023 0.4217 -0.0230 -5.17% 0.4447 0.4464 0.4097
Sep 20, 2023 0.4414 -0.0003 -0.07% 0.4417 0.4595 0.4389
Sep 19, 2023 0.4440 -0.0046 -1.03% 0.4486 0.4576 0.4424
Sep 18, 2023 0.4387 -0.0397 -8.30% 0.4784 0.4866 0.4387
Sep 15, 2023 0.4873 -0.0262 -5.10% 0.5135 0.5135 0.4824
Sep 14, 2023 0.5077 -0.0037 -0.72% 0.5114 0.5242 0.5076
Sep 13, 2023 0.5125 -0.0241 -4.49% 0.5366 0.5384 0.5124
Sep 12, 2023 0.5332 0.0248 4.88% 0.5084 0.5427 0.5084
Sep 11, 2023 0.5111 -0.0053 -1.03% 0.5164 0.5259 0.5010
Sep 8, 2023 0.5294 0.0320 6.43% 0.4974 0.5364 0.4974
Sep 7, 2023 0.4845 -0.0252 -4.94% 0.5097 0.5105 0.4574
Sep 6, 2023 0.5094 -0.0269 -5.02% 0.5363 0.5384 0.4990
Sep 5, 2023 0.5386 0.0123 2.34% 0.5263 0.5512 0.5153
Sep 1, 2023 0.5176 0.0211 4.25% 0.4965 0.5245 0.4916

Genprex, Inc. Events

Time (UTC) Country Event
Tuesday, November 14, 2023

Time (UTC)

20:04

Country

US

Event

Q3 2023 Genprex Inc Earnings Release
Q3 2023 Genprex Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 0 0 0 0 0
Revenue 0 0 0 0 0
Total Operating Expense 23.8307 20.6701 17.9616 10.6827 12.3635
Selling/General/Admin. Expenses, Total 12.2951 11.6767 10.6359 8.7026 11.3862
Research & Development 11.5101 8.97087 7.30292 1.96701 0.97143
Depreciation / Amortization 0.02558 0.02253 0.02278 0.01307 0.00589
Operating Income -23.8307 -20.6701 -17.9616 -10.6827 -12.3635
Net Income Before Taxes -23.7406 -20.665 -17.9428 -10.6548 -12.3723
Net Income After Taxes -23.7406 -20.665 -17.9428 -10.6548 -12.3723
Net Income Before Extra. Items -23.7406 -20.665 -17.9428 -10.6548 -12.3723
Net Income -23.7406 -20.665 -17.9428 -10.6548 -12.3723
Income Available to Common Excl. Extra. Items -23.7406 -20.665 -17.9428 -10.6548 -12.3723
Income Available to Common Incl. Extra. Items -23.7406 -20.665 -17.9428 -10.6548 -12.3723
Dilution Adjustment
Diluted Net Income -23.7406 -20.665 -17.9428 -10.6548 -12.3723
Diluted Weighted Average Shares 47.9521 47.0973 35.5229 16.027 13.771
Diluted EPS Excluding Extraordinary Items -0.49509 -0.43877 -0.5051 -0.6648 -0.89843
Dividends per Share - Common Stock Primary Issue
Diluted Normalized EPS -0.49509 -0.43877 -0.5051 -0.6648 -0.89843
Interest Income (Expense), Net Non-Operating 0.0901 0.00513 0.01881 0.02791 -0.0088
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 0 0 0 0 0
Revenue 0 0
Total Operating Expense 8.03574 9.27125 6.82163 6.11065 5.77039
Selling/General/Admin. Expenses, Total 4.05499 3.95708 3.49665 2.51112 2.83692
Research & Development 3.97692 5.31015 3.3189 3.59331 2.92693
Depreciation / Amortization 0.00384 0.00402 0.00608 0.00622 0.00654
Operating Income -8.03574 -9.27125 -6.82163 -6.11065 -5.77039
Interest Income (Expense), Net Non-Operating 0.05555 0.06847 0.0556 0.02788 0.00574
Net Income Before Taxes -7.98019 -9.20277 -6.76603 -6.08278 -5.76464
Net Income After Taxes -7.98019 -9.20277 -6.76603 -6.08278 -5.76464
Net Income Before Extra. Items -7.98019 -9.20277 -6.76603 -6.08278 -5.76464
Net Income -7.98019 -9.20277 -6.76603 -6.08278 -5.76464
Income Available to Common Excl. Extra. Items -7.98019 -9.20277 -6.76603 -6.08278 -5.76464
Income Available to Common Incl. Extra. Items -7.98019 -9.20277 -6.76603 -6.08278 -5.76464
Diluted Net Income -7.98019 -9.20277 -6.76603 -6.08278 -5.76464
Diluted Weighted Average Shares 51.979 49.4716 48.0495 47.9847 47.8934
Diluted EPS Excluding Extraordinary Items -0.15353 -0.18602 -0.14081 -0.12676 -0.12036
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.15353 -0.18602 -0.14081 -0.12676 -0.12036
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 21.4732 39.1402 27.7044 2.97664 8.84707
Cash and Short Term Investments 20.9541 38.6289 27.3197 2.00249 8.60092
Cash 20.9541 38.6289 27.3197 2.00249 8.60092
Prepaid Expenses 0.48422 0.51135 0.38455 0.17172 0.23685
Total Assets 25.085 42.8623 31.3672 3.53423 9.26896
Property/Plant/Equipment, Total - Net 0.02303 0.04861 0.03944 0.04465 0.02435
Intangibles, Net 3.56703 3.66476 3.61267 0.4912 0.37945
Other Long Term Assets, Total 0.02182 0.00869 0.01074 0.02173 0.01809
Total Current Liabilities 2.81029 1.5853 0.45072 0.51068 0.38782
Accounts Payable 0.44293 0.9732 0.19297 0.43626 0.29507
Notes Payable/Short Term Debt 0 0 0 0.07443 0.09275
Total Liabilities 2.81029 1.5853 0.45072 0.51068 0.38782
Total Long Term Debt 0 0 0 0 0
Total Equity 22.2747 41.277 30.9165 3.02355 8.88114
Preferred Stock - Non Redeemable, Net
Common Stock 0.04811 0.04787 0.04312 0.01926 0.01524
Additional Paid-In Capital 125.054 119.247 89.2956 43.4837 38.6906
Retained Earnings (Accumulated Deficit) -102.828 -78.0179 -58.4222 -40.4795 -29.8247
Total Liabilities & Shareholders’ Equity 25.085 42.8623 31.3672 3.53423 9.26896
Total Common Shares Outstanding 48.106 47.8747 43.1177 19.2638 15.2392
Total Receivables, Net 0.03485 0 0.00013 0.00066 0.0093
Accounts Receivable - Trade, Net 0.03485 0 0.00013 0.00066 0.0093
Total Inventory 0.80178
Other Current Liabilities, Total 2.36736 0.6121 0.25776
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Total Current Assets 19.9421 21.4732 26.3082 30.9008 35.7031
Cash and Short Term Investments 18.0828 20.9541 25.5161 30.053 34.5553
Cash 18.0828 20.9541 25.5161 30.053 34.5553
Total Receivables, Net 0 0.03485 0.03485 0.03217
Accounts Receivable - Trade, Net 0 0.03485 0.03485 0.03217
Total Inventory
Prepaid Expenses 1.85934 0.48422 0.75728 0.8478 1.1156
Total Assets 23.3201 25.085 29.9458 34.5651 39.4094
Property/Plant/Equipment, Total - Net 0.01902 0.02303 0.02911 0.03533 0.04188
Intangibles, Net 3.33712 3.56703 3.58671 3.61897 3.65444
Other Long Term Assets, Total 0.02182 0.02182 0.02182 0.01 0.01
Total Current Liabilities 4.83522 2.81029 2.45731 2.15384 2.38482
Accounts Payable 2.21225 0.44293 0.68387 0.68332 1.25298
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 2.62296 2.36736 1.77344 1.47052 1.13184
Total Liabilities 4.83522 2.81029 2.45731 2.15384 2.38482
Total Long Term Debt 0 0 0 0 0
Total Equity 18.4849 22.2747 27.4885 32.4113 37.0246
Common Stock 0.05197 0.04811 0.04802 0.0479 0.04788
Additional Paid-In Capital 130.463 125.054 122.433 121.273 120.717
Retained Earnings (Accumulated Deficit) -112.031 -102.828 -94.9924 -88.9097 -83.7403
Total Liabilities & Shareholders’ Equity 23.3201 25.085 29.9458 34.5651 39.4094
Total Common Shares Outstanding 51.9741 48.106 48.0203 47.8983 47.8797
Other Equity, Total
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -23.7406 -19.5956 -17.9428 -10.6548 -12.3723
Cash From Operating Activities -17.779 -14.2849 -13.9351 -6.91872 -6.84653
Cash From Operating Activities 0.02558 0.02253 0.02278 0.01307 0.00589
Non-Cash Items 4.73194 4.27821 4.24619 3.52998 5.43538
Changes in Working Capital 1.20414 1.00995 -0.26128 0.19299 0.08454
Cash From Investing Activities 0.09773 -0.0838 -2.33725 -0.9469 -0.10332
Capital Expenditures -0.05974 -0.07244 -0.12799 -0.14512 -0.10332
Cash From Financing Activities 0.00643 25.6779 41.5895 1.26719 15.3895
Issuance (Retirement) of Stock, Net 0.00643 25.6779 41.5895 1.26719 15.3895
Net Change in Cash -17.6748 11.3092 25.3172 -6.59843 8.43967
Other Investing Cash Flow Items, Total 0.15747 -0.01136 -2.20926 -0.80178
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -9.20277 -23.7406 -16.9746 -10.8918 -5.30982
Cash From Operating Activities -6.93244 -17.779 -13.1926 -8.62165 -4.0717
Cash From Operating Activities 0.00402 0.02558 0.0195 0.01327 0.00673
Non-Cash Items 1.33212 4.73194 3.18436 2.0261 1.05744
Cash Taxes Paid
Cash Interest Paid
Changes in Working Capital 0.93421 1.20414 0.57811 0.23078 0.17395
Cash From Investing Activities -0.01963 0.09773 0.07805 0.0458 -0.00184
Capital Expenditures -0.01963 -0.05974 -0.03974 -0.02369 -0.00184
Other Investing Cash Flow Items, Total 0.15747 0.11779 0.06949
Cash From Financing Activities 4.08078 0.00643 0.00175 0 0
Issuance (Retirement) of Stock, Net 4.08078 0.00643 0.00175 0
Net Change in Cash -2.87128 -17.6748 -13.1128 -8.57586 -4.07354
Financing Cash Flow Items 0

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Genprex, Inc. Company profile

About Genprex Inc

Genprex, Inc. is a clinical-stage gene therapy company focused on developing treatments for cancer and diabetes. The Company's lead cancer drug candidate, REQORSA Immunogene therapy drug (also referred to as GPX-001), is being developed to treat non-small cell lung cancer (NSCLC). The active agent in REQORSA is a TUSC2 gene expressing plasmid that is encapsulated in a DOTAP cholesterol nanoparticle. TUSC2 is a tumor suppressor gene which has both tumor killing (via apoptosis) and immunomodulatory effects. The Company utilizes its ONCOPREX Nanoparticle Delivery System to deliver the TUSC2 gene expressing plasmid to cancer cells. Its diabetes gene therapy, also referred to as GPX-002, is designed to work by transforming alpha cells in the pancreas into functional beta-like cells, which can produce insulin but are distinct enough from beta cells to evade the body's immune system.

Financial summary

BRIEF: For the nine months ended 30 September 2021, Genprex Inc revenues was not reported. Net loss increased 9% to $13.9M. Higher net loss reflects General and administrative increase of 13% to $8.8M (expense), Research and development increase of 3% to $5.1M (expense), Interest Income decrease of 76% to $4K (income). Basic Earnings per Share excluding Extraordinary Items increased from -$0.39 to -$0.30.

Industry: Bio Therapeutic Drugs

1601 Trinity Street, Bldg. B
Suite 3.322
78712

Income Statement

  • Annual
  • Quarterly

News

How to Trade The Triple Top

Welcome to Part 5 of our 7-part Power Patterns series. In this series, we'll be equipping you with the skills to trade some of the most indicative price patterns which occur on any timeframe in every market.

14:13, 27 September 2023
USA flag on the background of stock charts. Financial system in USA

Q4 lookahead: US indices starting to show signs of trouble?

US indices start to draw attention as traders focus on the outlook for Q4.

07:20, 27 September 2023

USD/JPY Climbs Towards Key Highs

USDJPY’s powerful long-term uptrend has been reignited after last week’s sharply contrasting policy statements from the Federal Reserve and Bank of Japan.

11:32, 26 September 2023

EUR/USD tests key support

EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.

14:32, 21 September 2023
Bank of England building

BoE leaves rates unchanged, GBP drops further as investors look for more clarity

The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August

11:45, 21 September 2023
British banknotes and coins photographed directly above. The coins are in a stack, placed on top of the banknotes.

GBP softer after CPI surprise, JPY focused on any further hints from Ueda

GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.

12:42, 20 September 2023

How to Trade The Break & Retest

In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.

11:59, 20 September 2023

People also watch

BTC/USD

27,089.45 Price
+0.520% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 85.00

Oil - Crude

90.04 Price
-1.230% 1D Chg, %
Long position overnight fee 0.0661%
Short position overnight fee -0.0881%
Overnight fee time 21:00 (UTC)
Spread 0.030

XRP/USD

0.52 Price
-3.480% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01192

ETH/USD

1,685.06 Price
+0.890% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 5.40

Still looking for a broker you can trust?

Join the 555.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading